SCP-999
Safe
~
medium confidence
SCP-999
Expected annual
$598K
One-time setup
$502K
Annual recurring
$573K
Personnel
7
One-time startup costs are approximately $470,500, largely driven by containment construction, research setup, and an incident reserve; ongoing annual costs are approximately $573,250/yr driven primarily by staff wages (caretakers + security), recurring research/monitoring, insurance/legal, and contingency. Pursuing optional pharmacological R&D would dramatically increase multi-year costs into the millions.
One-Time Capital Costs
Total: $502K
Annual Recurring Costs
Total: $573K/yr
Cost Scenarios
📊
Baseline
(baseline)
$573K/yr
Normal year with containment, monitoring, routine research follow-ups, and no major incidents.
routine_operations
scheduled_research_follow-up
regular_maintenance
🚨
Minor Incident
$598K/yr
Small accidental exposure, minor enclosure damage, or staff injury requiring medical care and modest repairs/PR/legal actions.
accidental_overexposure
feeding_error
small_containment_damage
🚨
Major Breach
$873K/yr
Public exposure or larger containment breach leading to significant legal, PR, repair, and replacement costs.
unauthorized_offsite_movement
public_exposure
large_scale_property_damage
🚨
Research Breakthrough Requiring Scale Up
$1.6M/yr
Discovery of pharmacologically valuable compounds leading to initiation of costly R&D and regulatory programs.
isolation_of_active_compounds
decision_to_pursue_drug_development
external_partnerships/clinical_trials
Personnel
7 total
| Role | Count | Notes |
|---|---|---|
| Animal Technician / Handler | 2 | [#5] Two full-time handlers to cover daily feeding, cleaning, enrichment, and supervised interactions. |
| Security Officer / MTF Agent | 4 | [#6] Four full-time security personnel for perimeter/site security and enforcement of no off-site rules. |
| Veterinary / Medical Support (contractor) | 1 | [#7] Part-time contracted veterinary/medical support (0.1–0.25 FTE equivalent) available as needed. |
Confidence Notes
Containment and staffing costs are well-characterized and based on provided estimates; uncertainty remains for research follow-ups, optional pharmacological R&D (large range), and site-specific overhead which reduces confidence to medium.